🇺🇸 FDA
Patent

US 9428490

Nuclear transport modulators and uses thereof

granted A61PA61P13/12A61P29/00

Quick answer

US patent 9428490 (Nuclear transport modulators and uses thereof) held by Karyopharm Therapeutics Inc. expires Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Karyopharm Therapeutics Inc.
Grant date
Tue Aug 30 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 25 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61P, A61P13/12, A61P29/00, A61P31/12, A61P35/00